Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic abnormality in the anaplastic lymphoma kinase…
Tag: Treatment Options For Lung Cancer
Post-Surgical Lung Cancer Treatments
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. But, as lung cancer surgery…
Health Benefits of Fennel for Lung Cancer Patients
Lung Cancer is a serious health problem having no respect for age and sex and can affect any person at any interval of time. Various ayurvedic herbs help lung cancer patients in…
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic Oncology. The purpose behind the study…
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of lung…
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of Barcelona and Hospital…
Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating awareness about this deadly disease is…